Unlike other techniques which only provide qualitative observations of proximity or colocalisation, QF-Pro® provides highly specific quantitative read-outs of functional biomarker events (interactions and post-translational modifications) in fixed patient samples and cell lines.
This is because QF-Pro® operates at an unprecedented resolution and dynamic range, which allows it to precisely quantify and map these molecular events in the tumor microenvironment in a direct, mechanistic, manner.

The in-situ detection of these cellular signalling events allows for the discovery and use of a whole new family of relevant novel biomarker functions to support the personalised medicine agenda in a range of pathologies.

HAWK Biosystems are already working for a growing number of research groups and pharmaceutical companies, opening up brand new avenues for precision medicine and companion diagnostics.